Navigation Links
Palatin Technologies Announces Option for License to Bremelanotide in Europe
Date:11/13/2013

aceutical companies on commercialization of bremelanotide in the United States, and hope to be able to select a potential partner this year and proceed to negotiation of definitive agreements early next year."

About Palatin Technologies

Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin's website at http://www.palatin.com

Forward-looking Statements

Statements in this press release that are not historical facts, including statements about future expectations of Palatin Technologies, Inc. such as statements about the prospects of entering into one or more license agreements relating to bremelanotide, potential clinical trial results with bremelanotide, potential actions by regulatory agencies in the United States or Europe relating to bremelanotide, regulatory plans, development programs and the market potential of bremelanotide are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and as that term is defined in the Private Securities Litigation Reform Act of 1995. Palatin intends that such forward-looking statements be subject to the safe harbors created thereby. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause Palatin's actual results to be materially different from its historical results or from any results expressed or implied by such forward-looking statements. Palatin's act
'/>"/>

SOURCE Palatin Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Palatin Technologies Announces Issuance of Two Natriuretic Peptide Receptor-Specific Mimetic Patents
2. Palatin Technologies, Inc. To Report First Quarter Fiscal Year 2014 Results; Teleconference and Webcast to be held on November 14, 2013
3. Palatin Technologies Reports Successful Completion Of Device Bioequivalence Trial
4. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2013 Results
5. Palatin Technologies, Inc. To Report Fiscal Year 2013 Fourth Quarter Results
6. Palatin Technologies Announces Notification of Patent Allowance On Melanocortin Receptor-1 Specific Peptides
7. Palatin Technologies Announces Last Patient Completed Treatment In Phase 2B Bremelanotide Female Sexual Dysfunction Trial
8. Patient Safety Technologies Reports Third Quarter 2013 Results
9. BioSpecifics Technologies Corp. Reports Third Quarter 2013 Financial Results
10. Certifications, Presentation of Study Results and Earnings Releases - Research Report on Agilent, Mindray, Bard, Tornier, and Life Technologies
11. Study Assesses New Tools, Technologies, and Approaches for Understanding and Communicating with Consumers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)...  Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) ... announced registered offering of common shares in ... the Offering, the Company issued 7,286,432 common shares at ... proceeds of approximately $1.45 billion. On March 18, 2015, ... Commission a final prospectus supplement to its effective shelf ...
(Date:3/27/2015)... 27, 2015 The International Myeloma Foundation (IMF) ... while working toward prevention and a cure – today ... a federal resolution (H. Res. 174) that supports the ... Multiple Myeloma Awareness Month." Currently there are ... more than 110,000 new cases are diagnosed yearly, according ...
(Date:3/27/2015)... 27, 2015  Johnson & Johnson (NYSE: JNJ ) ... (Eastern Time) on Thursday, April 23, 2015, from the State ... Investors and other interested parties may access the live ... at www.jnj.com and clicking on the webcast icon. ... be made available a few hours after the live meeting ...
Breaking Medicine Technology:Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 2Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 3The International Myeloma Foundation (IMF) Secures the Introduction of a Federal Resolution Recognizing March 2015 as "National Multiple Myeloma Awareness Month" 2
... NDI has launched the NDI Healthcare Fund, a ... technologies.  The Fund recently raised $8 million from ... of Ohio. (Logo: http://photos.prnewswire.com/prnh/20110131/DC38962LOGO) ... both seed-stage neurodevice companies and technologies," said Geoff ...
... program could cost taxpayers an additional $1.6 billion next year, ... for the health care program covering more than 2 million ... the Governor,s Office of Health Transformation.  This new information comes ... by the Pharmaceutical Care Management Association (PCMA) that ...
Cached Medicine Technology:NDI Announces New Healthcare Venture Fund 2PCMA: Ohio's Medicaid Program Could Save $135 Million 2PCMA: Ohio's Medicaid Program Could Save $135 Million 3PCMA: Ohio's Medicaid Program Could Save $135 Million 4
(Date:3/28/2015)... March 28, 2015 "Necrorun" was featured ... takes a look at the latest and coolest applications ... Troohey, the host of NewsWatch and technology expert, conducted ... is an entertaining endless runner game with knights, nature, ... was released in 2009, according to Eurogamer. The popularity ...
(Date:3/28/2015)... With more than 4,500 scientists, ... osteoporosis, osteoarthritis and musculoskeletal diseases gathered here for ... the first time in the 17-year history of ... hot-button topic is an emerging non-pharmaceutical protocol for ... principles of Wolff’s law, osteogenic loading at multiples ...
(Date:3/28/2015)... The California-based leading wig brand UniWigs ... shopping on UniWigs during the Easter Holidays from today ... promotion on April Fools’ Day. , As the winter ... the corner. Easter Festival, with religious origins to countries ... holiday after Christmas. The best wig provider, UniWigs, would ...
(Date:3/28/2015)... March 28, 2015 India Network ... is made available to all visitors who purchase the ... All members are encouraged to purchase the insurance program ... lack of proper coverage for pre-existing medical conditions. Parents ... or two medical conditions with serious consequences to their ...
(Date:3/28/2015)... Chicago, IL (PRWEB) March 28, 2015 Centurion ... medical equipment auction on Thursday, April 2 at their Las ... Las Vegas, NV 89081. The sale, which consists of equipment ... will begin promptly at 9 a.m. PDT. , Buyers ... radiology and surgery equipment. “We are a one-stop-shop,” said Erik ...
Breaking Medicine News(10 mins):Health News:A Grim Endless Runner Game Was Featured on NewsWatch Television on January 30, 2015 2Health News:Non-Drug Protocol for Building Bone Density Expected to Steal Spotlight at World Congress on Osteoporosis 2Health News:UniWigs Is Sending Out Mysterious Gifts During the Easter Holidays 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 3Health News:Medical Equipment Auction to Take Place in North Las Vegas 2
... PITTSBURGH, June 17 Mylan Inc. (Nasdaq: MYL ... received approval from the U.S. Food and Drug Administration (FDA) ... Capsules USP, 22.5 mg. This strength is in addition to ... the product. , , Temazepam Capsules are the generic ...
... Dad,s Personal Wellness ,Toolbox, Gets a Makeover with the Omron HEM-780 Blood ... Day, all eyes are on dad. From where to treat him ... role in the family and showing him how much we care. ... So this Father,s Day, rather than giving the usual cordless drill ...
... bankruptcy, and divorce skyrocket with the global recession, the people ... burden of these concerns can be agonizing, affecting both mental ... How to Defeat Stress Without Going Through the Embarrassment of ... of stress life can throw your way. Dr. Theu explains ...
... Footprint , , - Transaction Expected to be Accretive to ... - Enhances Watson,s Long Term Growth Profile , , MORRISTOWN, ... ) today announced that it has entered into a definitive agreement ... and stock. The combination of Watson and Arrow will result in ...
... , , , Oncology Test Further ... Calif., June 17 Cepheid (Nasdaq: CPHD ) today ... be marketed as a CE IVD product under the European Directive ... the test now detects the BCR-ABL chromosomal translocation in about 2 ...
... Group has revealed that despite the drooping economy Scots men ... in for moob removal surgery and finally getting their insecurities ... Transform Cosmetic Surgery Group has revealed that despite the ... this summer by booking in for moob removal surgery and ...
Cached Medicine News:Health News:This Father's Day Give Dad a Gift Straight for the Heart 2Health News:This Father's Day Give Dad a Gift Straight for the Heart 3Health News:'7 Proven Steps: How to Defeat Stress Without Going Through the Embarrassment of Counseling': Proven Ways to Defeat Stress 2Health News:'7 Proven Steps: How to Defeat Stress Without Going Through the Embarrassment of Counseling': Proven Ways to Defeat Stress 3Health News:Watson to Acquire Arrow Group 2Health News:Watson to Acquire Arrow Group 3Health News:Watson to Acquire Arrow Group 4Health News:Watson to Acquire Arrow Group 5Health News:Watson to Acquire Arrow Group 6Health News:Watson to Acquire Arrow Group 7Health News:Cepheid Announces European Release of Improved Test for BCR-ABL Chromosomal Translocation Associated With Chronic Myelogenous Leukemia (CML) 2Health News:Cepheid Announces European Release of Improved Test for BCR-ABL Chromosomal Translocation Associated With Chronic Myelogenous Leukemia (CML) 3Health News:Cepheid Announces European Release of Improved Test for BCR-ABL Chromosomal Translocation Associated With Chronic Myelogenous Leukemia (CML) 4Health News:Scots Men Get the Issue of Moobs Off Their Chests in Time for Summer - Male Surgery in Scotland Sees 80 Per Cent Growth 2Health News:Scots Men Get the Issue of Moobs Off Their Chests in Time for Summer - Male Surgery in Scotland Sees 80 Per Cent Growth 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: